Energy Recovery, Inc. (ERII) Financials
ERII Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 244.3 million | 28.2 million |
2023-12-31 | 253.0 million | 33.2 million |
2023-09-30 | 222.7 million | 28.6 million |
2023-06-30 | 209.7 million | 27.9 million |
ERII Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 5.7 million | 3.3 million |
2023-12-31 | 12.4 million | 2.2 million |
2023-09-30 | 7.3 million | 1.8 million |
2023-06-30 | -4.7 million | 1.7 million |
ERII Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2024-03-31 | -8.3 million |
2023-12-31 | 19.8 million |
2023-09-30 | 9.7 million |
2023-06-30 | -1.7 million |
ERII Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 117.4 million | - | 12.8 million |
2023-12-31 | 108.5 million | - | 13.3 million |
2023-09-30 | 105.9 million | - | 13.7 million |
2023-06-30 | 97.5 million | - | 14.2 million |
ERII Shares Outstanding
ERII Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 824000 | 4.4 million | 7.6 million | 6.2 million |
2023-12-31 | 1.4 million | 5.0 million | 7.2 million | 6.8 million |
2023-09-30 | 412000 | 4.0 million | 3.1 million | 4.8 million |
2023-06-30 | 570000 | 3.8 million | 7.3 million | 5.1 million |
ERII Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 12.1 million | 5.0 million |
2023-12-31 | 57.2 million | 17.7 million |
2023-09-30 | 37.0 million | 11.2 million |
2023-06-30 | 20.7 million | 7.2 million |
ERII
Price: $13.64
52 week price:
Earnings Per Share: 0.37 USD
P/E Ratio: 58.74
Exchange: NMS
Sector: Industrials
Industry: Pollution & Treatment Controls
Volume: 42325
Ebitda: 2.7 millionMarket Capitalization: 782.0 million